Corient Private Wealth’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.72M Sell
9,673
-9,023
-48% -$2.62M ﹤0.01% 1102
2025
Q4
$5.53M Buy
18,696
+10,656
+133% +$3.21M ﹤0.01% 1006
2025
Q3
$1.98M Sell
8,040
-7,075
-47% -$1.43M ﹤0.01% 1067
2025
Q2
$2.36M Buy
15,115
+6,718
+80% +$714K ﹤0.01% 965
2025
Q1
$662K Buy
8,397
+247
+3% +$26.2K ﹤0.01% 1464
2024
Q4
$752K Buy
8,150
+650
+9% +$50.8K ﹤0.01% 1435
2024
Q3
$383K Sell
7,500
-50
-0.7% -$2.58K ﹤0.01% 1886
2024
Q2
$433K Buy
7,550
+50
+0.7% +$2.52K ﹤0.01% 1723
2024
Q1
$337K Hold
7,500
﹤0.01% 1830
2023
Q4
$220K Sell
7,500
-10,956
-59% -$291K ﹤0.01% 2025
2023
Q3
$443K Sell
18,456
-2,784
-13% -$57K ﹤0.01% 1561
2023
Q2
$307K Buy
21,240
+37
+0.2% +$458 ﹤0.01% 1685
2023
Q1
$274K Sell
21,203
-452
-2% -$5.78K ﹤0.01% 1654
2022
Q4
$245K Buy
+21,655
New +$228K ﹤0.01% 1412

Other funds holding CLS

Corient Private Wealth's CLS Position: Q1 2026 in Review

Corient Private Wealth reduced its Celestica (CLS) stake by 48% in Q1 2026, selling an estimated $2.62M and leaving 9,673 shares worth $2.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Corient Private Wealth first reported a position in CLS in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.53M in Q4 2025. 773 funds tracked by Wall St. Rank hold CLS as of Q1 2026.

  • Corient Private Wealth held 9,673 shares of Celestica worth $2.72M as of Q1 2026.
  • Corient Private Wealth sold 9,023 Celestica shares in Q1 2026, an estimated $2.62M.
  • Celestica made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1102 holding.
  • Corient Private Wealth first reported a position in Celestica in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Celestica position peaked at $5.53M in Q4 2025.
  • 773 funds tracked by Wall St. Rank held Celestica as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.